Izumi N - Search Results

1

REFLECT-a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset.

Yamashita T, Kudo M, Ikeda K, Izumi N, Tateishi R, Ikeda M, Aikata H, Kawaguchi Y, Wada Y, Numata K, Inaba Y, Kuromatsu R, Kobayashi M, Okusaka T, Tamai T, Kitamura C, Saito K, Haruna K, Okita K, Kumada H. Yamashita T, et al. Among authors: izumi n. J Gastroenterol. 2020 Jan;55(1):113-122. doi: 10.1007/s00535-019-01642-1. Epub 2019 Nov 12. J Gastroenterol. 2020. PMID: 31720835 Free PMC article. Clinical Trial.

2

Rapid decrease of plasma HCV RNA in early phase of twice daily administration of 3 MU doses interferon-beta in patients with genotype 1b hepatitis C infection: a multicenter randomized study.

Izumi N, Kumada H, Hashimoto N, Harada H, Imawari M, Zeniya M, Toda G. Izumi N, et al. Dig Dis Sci. 2001 Mar;46(3):516-23. doi: 10.1023/a:1005686829416. Dig Dis Sci. 2001. PMID: 11318525 Clinical Trial.

3

Pharmacokinetics of ribavirin in combined interferon-alpha 2b and ribavirin therapy for chronic hepatitis C virus infection.

Tsubota A, Hirose Y, Izumi N, Kumada H. Tsubota A, et al. Among authors: izumi n. Br J Clin Pharmacol. 2003 Apr;55(4):360-7. doi: 10.1046/j.1365-2125.2003.01780.x. Br J Clin Pharmacol. 2003. PMID: 12680884 Free PMC article. Clinical Trial.

4

Mutations in the NS5B region of the hepatitis C virus genome correlate with clinical outcomes of interferon-alpha plus ribavirin combination therapy.

Hamano K, Sakamoto N, Enomoto N, Izumi N, Asahina Y, Kurosaki M, Ueda E, Tanabe Y, Maekawa S, Itakura J, Watanabe H, Kakinuma S, Watanabe M. Hamano K, et al. Among authors: izumi n. J Gastroenterol Hepatol. 2005 Sep;20(9):1401-9. doi: 10.1111/j.1440-1746.2005.04024.x. J Gastroenterol Hepatol. 2005. PMID: 16105128

5

Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts.

Okanoue T, Itoh Y, Minami M, Hashimoto H, Yasui K, Yotsuyanagi H, Takehara T, Kumada T, Tanaka E, Nishiguchi S, Izumi N, Sata M, Onji M, Yamada G, Okita K, Kumada H. Okanoue T, et al. Among authors: izumi n. Hepatol Res. 2008 Jan;38(1):27-36. doi: 10.1111/j.1872-034X.2007.00217.x. Hepatol Res. 2008. PMID: 18039201

6

Potential relevance of cytoplasmic viral sensors and related regulators involving innate immunity in antiviral response.

Asahina Y, Izumi N, Hirayama I, Tanaka T, Sato M, Yasui Y, Komatsu N, Umeda N, Hosokawa T, Ueda K, Tsuchiya K, Nakanishi H, Itakura J, Kurosaki M, Enomoto N, Tasaka M, Sakamoto N, Miyake S. Asahina Y, et al. Among authors: izumi n. Gastroenterology. 2008 May;134(5):1396-405. doi: 10.1053/j.gastro.2008.02.019. Epub 2008 Feb 14. Gastroenterology. 2008. PMID: 18471516

7

Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C: a Japanese multi-center study.

Okanoue T, Itoh Y, Hashimoto H, Yasui K, Minami M, Takehara T, Tanaka E, Onji M, Toyota J, Chayama K, Yoshioka K, Izumi N, Akuta N, Kumada H. Okanoue T, et al. Among authors: izumi n. J Gastroenterol. 2009;44(9):952-63. doi: 10.1007/s00535-009-0087-x. Epub 2009 Jun 11. J Gastroenterol. 2009. PMID: 19517057

8

Prolonged treatment with pegylated interferon alpha 2b plus ribavirin improves sustained virological response in chronic hepatitis C genotype 1 patients with late response in a clinical real-life setting in Japan.

Watanabe S, Enomoto N, Koike K, Izumi N, Takikawa H, Hashimoto E, Moriyasu F, Kumada H, Imawari M; PERFECT Study Group. Watanabe S, et al. Among authors: izumi n. Hepatol Res. 2010 Feb;40(2):135-44. doi: 10.1111/j.1872-034X.2009.00567.x. Epub 2009 Sep 25. Hepatol Res. 2010. PMID: 19788694

9

Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis.

Kurosaki M, Sakamoto N, Iwasaki M, Sakamoto M, Suzuki Y, Hiramatsu N, Sugauchi F, Yatsuhashi H, Izumi N. Kurosaki M, et al. Among authors: izumi n. J Gastroenterol. 2011 Mar;46(3):401-9. doi: 10.1007/s00535-010-0322-5. Epub 2010 Sep 10. J Gastroenterol. 2011. PMID: 20830599

10

Liver Cancer Working Group report.

Kudo M, Han KH, Kokudo N, Cheng AL, Choi BI, Furuse J, Izumi N, Park JW, Poon RT, Sakamoto M. Kudo M, et al. Among authors: izumi n. Jpn J Clin Oncol. 2010 Sep;40 Suppl 1:i19-27. doi: 10.1093/jjco/hyq123. Jpn J Clin Oncol. 2010. PMID: 20870915

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

848 results

Search Page